Notifications of transactions by PDMRs

Assura

14/08/2025 15:30

RNS Number : 4024V

Assura PLC

14 August 2025

 

14 August 2025

Assura plc

("the Company")

Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that the following transactions by a named PDMR and their connected persons took place on 13 August 2025.

PDMR
Position
Shareholding on 12 August 2025
Shares sold
Shareholding post transaction
Ed Smith
Chairman
166,649
166,649
Nil

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Ed Smith
2
Reason for the notification
a)
Position/status
Chairman
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.4904 GBP
116,163
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.4904 GBP
116,163
£56,966.34 GBP
e)
Date of the transaction
13 August 2025
f)
Place of the transaction
XLON

 

 

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jenny Smith
2
Reason for the notification
a)
Position/status
Connected person of Ed Smith
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.4924 GBP
50,486
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.4924 GBP
50,486
£24,859.31 GBP
e)
Date of the transaction
13 August 2025
f)
Place of the transaction
XLON

 

 

For more information, please contact:

Assura plc
Tel:01925 945354
Orla Ball, Company Secretary
David Purcell, Investor Relations Director
Email:Investor@assura.co.uk
FGS Global
Gordon Simpson
 James Thompson
Tel:0207 251 3801
Email:Assura@fgsglobal.com

 

For more information, please contact:

Assura plc
Tel:0161 515 2043
David Purcell, Investor Relations Director
Email:Investor@assura.co.uk
FGS Global
Gordon Simpson
Tel:0207 251 3801
Email:Assura-LON@fgsglobal.com

 

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices and has a secondary listing on the Johannesburg Stock Exchange.

At Assura we BUILD for health and as the first FTSE 250 certified B Corp we are committed to keeping ESG at the heart of our strategy, creating Healthy Environments (E) and Healthy Communities (S) and maintaining a Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHGPUAPRUPAGWC